Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Dow
Colorcon
Julphar
Fuji
Johnson and Johnson
Healthtrust
Queensland Health
Daiichi Sankyo

Generated: December 12, 2017

DrugPatentWatch Database Preview

ETHAMIDE Drug Profile

« Back to Dashboard

When do Ethamide patents expire, and when can generic versions of Ethamide launch?

Ethamide is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in ETHAMIDE is ethoxzolamide. Additional details are available on the ethoxzolamide profile page.
Drug patent expirations by year for ETHAMIDE

Medical Subject Heading (MeSH) Categories for ETHAMIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AllerganETHAMIDEethoxzolamideTABLET;ORAL016144-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
Cipla
Farmers Insurance
Queensland Health
Chinese Patent Office
Colorcon
Deloitte
Accenture
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot